SCHEMBL170797

SCHEMBL170797

C=Cc1ccc(O)c(O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.64
KDM4E B2RXH2 5/20 0.58
RAB9A P51151 2/20 0.58
PTGS2 P35354 1/20 0.58
TRPA1 O75762 1/20 0.57
POLB P06746 3/20 0.56
BLM P54132 3/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
GFER P55789 2/20 0.56
ALPL P05186 2/20 0.56
ALPI P09923 1/20 0.56
ALPG P10696 1/20 0.56
NQO2 P16083 1/20 0.54
ALDH1A1 P00352 5/20 0.52
CYP3A4 P08684 4/20 0.52
HSD17B10 Q99714 4/20 0.52
ALOX12 P18054 3/20 0.52
CYP2C9 P11712 3/20 0.52
HIF1A Q16665 3/20 0.52
MEN1 O00255 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29403669 1.00 LCK (0.64) LCKKDM4ERAB9APTGS2TRPA1
Formic Acid SCHEMBL29030387 0.91 KDM4E (0.61) LCKKDM4ERAB9APTGS2TRPA1
Ethylene Glycol SCHEMBL3050436 0.91 LCK (0.54) LCKKDM4ERAB9APTGS2TRPA1
Styrene SCHEMBL4416848 0.89 ALDH1A1 (0.58) LCKKDM4ERAB9APTGS2TRPA1
Acetone SCHEMBL22719872 0.89 IAPP (0.58) LCKKDM4ERAB9APTGS2TRPA1
Sulfuric Acid SCHEMBL23249872 0.89 KDM4E (0.54) LCKKDM4ERAB9APTGS2TRPA1
Acetic Acid SCHEMBL29030379 0.87 IAPP (0.56) LCKKDM4ERAB9APTGS2TRPA1
SCHEMBL29502822 0.84 TRPA1 (0.52) LCKKDM4ERAB9APTGS2TRPA1
SCHEMBL8189039 0.84 LCK (0.47) LCKKDM4ERAB9APTGS2TRPA1
Pimagedine SCHEMBL5833459 0.82 LCK (0.45) LCKKDM4ERAB9APTGS2TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1017 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130861-A1 THERAPEUTIC NANOPARTICLES WITH ANTIOXIDANT AND IRON-CHELATION ACTIVITY UNIVERSITY OF OREGON (US) 2026-05-14 US claimed
WO-2026090621-A1 SYSTEMS, DEVICES, AND METHODS FOR SEPARATION OF METALS FROM WASTE, SCRAP, AND POST-CONSUMER PRODUCTS SUNCHEM INC. (US) 2026-04-30 WO claimed
US-12540228-B2 Cross linked surface coating and interfacial layer for a perovskite material photovoltaic device CUBICPV INC. (US) 2026-02-03 US claimed
US-12509590-B2 Composition of anticorrosion coatings and uses thereof PURDUE RESEARCH FOUNDATION (US) 2025-12-30 US claimed
CN-119876307-A Preparation method of high-purity cyanidin-3-glucoside-4-vinyl catechol 暨南大学 2025-04-25 CN claimed
US-12269908-B2 Large scale production of catechol-containing polymers PURDUE RESEARCH FOUNDATION (US) 2025-04-08 US claimed
CN-119591769-A Organic polymer carrier, Z-N catalyst, and preparation method and application thereof 中国石油天然气股份有限公司 2025-03-11 CN claimed
CN-119433778-A Production process of cotton fiber blended yarn 射阳县鸿昇纺织有限公司 2025-02-14 CN claimed
US-20240400838-A1 COMPOSITION OF ANTICORROSION COATINGS AND USES THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY 2024-12-05 US claimed
EP-4388050-A2 COMPOSITION OF ANTICORROSION COATINGS AND USES THEREOF Purdue Research Foundation (US) 2024-06-26 EP claimed
US-6664282-B2 For preparing and using libraries of compounds as well as individual compounds of the libraries; for screening compounds for combinatorial chemistry TORREY PINES INSTITUTE FOR MOLECULAR STUDIES 2003-12-16 US claimed
US-20030144195-A1 Therapeutic peptide-based constructs LITTLE ROGER G (US) 2003-07-31 US claimed
US-6545032-B1 Combinatorial libraries TORREY PINES INSTITUTE FOR MOLECULAR STUDIES 2003-04-08 US claimed
US-20020193608-A1 Synthesis of [3,5,7]--1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds ELABDELLAOUI HASSAN M (US) 2002-12-19 US claimed
US-6423825-B1 OCTA-, NONA-, DECA- OR POLYPEPTIDE; HEPARIN BINDING AND NEUTRALIZATION; ANTIPROLIFERATIVE AGENTS OF ENDOTHELIAL CELLS; ANGIOGENESIS INHIBITORS XOMA TECHNOLOGY LTD. (BM) 2002-07-23 US claimed
EP-1196440-A2 THERAPEUTIC PEPTIDES DERIVED FROM SUBSEQUENCES OF BPI XOMA Technology Ltd. (US) 2002-04-17 EP claimed
US-6355616-B1 FUNGICIDE OLIGOPEOTIDES XOMA (US) TECHNOLOGY LTD. 2002-03-12 US claimed
WO-2001000655-A2 THERAPEUTIC PEPTIDES DERIVED FROM SUBSEQUENCES OF BPI XOMA TECHNOLOGY LTD. (US) 2001-01-04 WO claimed
WO-2001000671-A1 DERIVATIVE COMPOUNDS XOMA TECHNOLOGY LTD. (US) 2001-01-04 WO claimed
US-5856107-A Combinatorial libraries of imidazol-pyrido-indole and imidazol-pyrido-benzothiophene derivatives, methods of making the libraries and compounds therein TREGA BIOSCIENCES, INC. (US) 1999-01-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130861-A1 THERAPEUTIC NANOPARTICLES WITH ANTIOXIDANT AND IRON-CHELATION ACTIVITY GPX1, TXN2, TFRC LCK 1990/4885KDM4E 3135/4885RAB9A 3018/4885
US-12540228-B2 Cross linked surface coating and interfacial layer for a perovskite material photovoltaic device HCN2, HCN1, BRSK1 LCK 935/4885KDM4E 451/4885RAB9A 1075/4885
US-20030144195-A1 Therapeutic peptide-based constructs LNPEP, SPPL2B, ENPEP LCK 3215/4885KDM4E 4874/4885RAB9A 3311/4885
US-20020193608-A1 Synthesis of [3,5,7]--1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds CYP3A7, CYP3A5, AADAC LCK 822/4885KDM4E 3280/4885RAB9A 672/4885
US-12509590-B2 Composition of anticorrosion coatings and uses thereof SDC2, CD47, SDC4 LCK 3864/4885KDM4E 204/4885RAB9A 4260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.